US priority review for AZ’ Tagrisso

18th December 2017 Uncategorised 0

US regulators are undertaking a speedy review of AstraZeneca’s application to market Tagrisso as first-line treatment for lung cancer.

More: US priority review for AZ’ Tagrisso
Source: News